Pharmacy Friends

Prime Therapeutics
  • 5.0 (12)
  • Health & Fitness

Pharmacy Friends is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future, and most importantly, what it means to you.

  1. Sep 24

    Autoimmune care: Seeing the full picture

    Autoimmune conditions are complex and treating them requires a coordinated approach that improves health outcomes and affordability. On the newest Pharmacy Friends, listen to Horizon Blue Cross Blue Shield of New Jersey’s Timothy O’Shea and Prime’s Sneha Sharma discuss how integrating pharmacy and medical benefits reduces fragmented care and supports clinically appropriate treatment. What you'll hear How biosimilars and optimized sites of care are improving access for patientsWhy connecting data can help improve treatment decisionsWhat payers should watch as new oral therapies and potential CAR T treatments reshape autoimmune care

  2. Jun 6

    Human-centered pharmacy: Putting the care in healthcare

    Learn how nurse-led care coordination supports members right after their specialty therapy starts. Learn how the compassionate experts at Prime help members understand their treatment, set expectations and get support when it’s needed.  Tune in to hear how nurse-led coordination is reducing costs and improving care for the better, including: Fewer early missteps through clear patient educationBetter member experience through personalized supportReduced urgent care and ER visits through early symptom management Chapters 02:22 - Introduction to care management 05:35 - Care management availability 06:45 - Patient impact of care management 10:17 - Common conditions that care management teams help with 11:52 - Caregiver assistance 14:23 - Better patient outcomes, means stronger health systems 17:33 - The "why" behind care management is about compassion 18:41 - Closing

    Human-centered pharmacy: Putting the care in healthcare

  3. Jun 6

    Accelerated drug approvals: The big questions facing payers

    Dive into the latest episode of Pharmacy Friends for a discussion of the FDA Commissioner’s National Priority Voucher pilot. While accelerated approvals may improve access to innovative therapies, what could a compressed decision-making window mean for evidence review, affordability assessment and implementation planning?   Prime experts Angela Sutton and Bob Greer explore the important roles clinical confidence and operational readiness will play in making solid coverage decisions. Hear what they’re most focused on, including: Managing drug spendAssessing coverage strategiesDetermining policy risk 00:00 Introduction 02:10 What's generating all the questions now? 04:35 FDA Hearing 05:50 Pro's and con's of accelerated drug approvals 11:05 Policy uncertainty and impact to payers 11:54 Impact of FDA leadership changes 12:24 Meeting the moment 15:26 Using data to make better decisions that need to be fast 18:39 What we would tell the acting FDA leadership that matters 23:15 Closing

    Accelerated drug approvals: The big questions facing payers

  4. Apr 21

    On-the-road @ AMCP Annual 2026: Innovative research and expert insights drive breakthroughs in health outcomes

    Recorded live in Nashville at AMCP Annual 2026, our latest Pharmacy Friends shares takeaways on how real-world medical and pharmacy data, pharmacist-led outreach, and benefit integration are shaping payer decision-making.   00:45 - Why real-time evidence matters 09:37 - High-touch pharmacist-to-prescriber outreach helps deliver hard-dollar savings. 23:51 – Rare disease insight and reinforcing the need for individualized management and payer case-management opportunities. 36:02 -- Why site of care in CAR-T and BiTE therapy matter 43:20 – Why mental health parity compliance in government programs matter now  52:55-- Integration signal by highlighting the value of coordinated care. These insights are foundational to how Prime delivers value to health care payers. Using evidence-driven expertise on how therapies are used, where gaps exist and which patients benefit most from additional support, Prime translates research into smarter clinical strategies and high-touch support for patients.    Dive into the real stories, smart insights, and everyday moments that bring the world of pharmacy and everyday life together—one authentic conversation at a time.

    On-the-road @ AMCP Annual 2026: Innovative research and expert insights drive breakthroughs in health outcomes

  5. Jan 29

    Assemble the Standards: Making Quality Second Nature at Prime

    Discover how Prime brings together industry recognized accreditation frameworks—like URAC, ISO, and NCQA—to create a unified, reliable approach to patient safety and operational excellence. In this episode, we break down how quality standards become everyday practice through embedded processes, continuous improvement, internal audits, and real world examples that demonstrate measurable impact for clients, members, and partners. 00:20: Intro 03:12: Importance of quality operations 15:50: Pharmacy accreditations on the frontline 22:15: Preparing for an emergency 23:25: Being a trusted partner 28:56: What's next in the quality universe? 31:52: New & emerging accreditations to watch 33:50: Closing

    Assemble the Standards: Making Quality Second Nature at Prime

  6. Jan 29

    Early-onset cancer: Screening, costs and what's next

    Early-onset cancers are rising—and they’re forcing people to rethink cancer, screenings and care models. What if cancer care strategy needs to start earlier—and last longer? This Pharmacy Friends conversation breaks down the rise in early-onset cancers and the practical implications for prevention, benefit design, and affordability. 00:00 Intro 02:30 Basics of cancer in younger people 07:52 Early onset cancer impact on health plans 11:14 Patient challenges and decision making 15:23 Impact on affordability 22:00 Importance of medical and pharmacy benefit integration 27:38 New ways of offering cancer care 30:41 Role that AI can play in patient care 33:26 Should health care adapt for best clinical outcomes 34:50 Being an advocate for the patient 38:49 Closing Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

    Early-onset cancer: Screening, costs and what's next

  7. Jan 21

    Reimagining the Pipeline: Cell & Gene Therapy Decisions That Shape Care

    During this episode of Pharmacy Friends you’ll hear about the rapidly evolving world of cell and gene therapy, highlighting its promise, complexity, and growing impact across the health care ecosystem. Learn about the foundational definitions, emerging clinical innovations, and the expanding pipeline of therapies expected to reach the market in the coming years. It also examines regulatory developments, forecasting approaches, financial considerations, and the human elements that shape patient and provider decision‑making. Through expert insights and real‑world examples, the conversation illustrates how Prime is helping stakeholders navigate this dynamic landscape while preparing for the transformative potential of next‑generation therapies. Listen to the latest episode of the “Pharmacy Friends” podcast Read the latest Cell & Gene Pipeline Outlook Learn more about how Prime manages cell and gene therapies In this episode: 03:46 What is Cell & Gene Therapy? 04:34 What is the Cell & Gene Therapy Pipeline? 08:13 Why pay attention to cell & gene therapies? 12:45: Collaboration with all stakeholders is important to get the right therapies to patients 20:35: Digging in new therapies that are on the horizon 22:56: Importance of the FDA commissioner's national priority voucher 25:52: What to consider when these therapies are an option 28:40: Is cost a barrier to these therapies? 31:41: 2026 cell and gene therapy outlook 36:18: Closing - books and fishing

    Reimagining the Pipeline: Cell & Gene Therapy Decisions That Shape Care

  8. 12/10/2025

    Beyond the Needle: Why Oral GLP-1s Matter Now

    Learn about the FDA’s new expedited approval process for oral GLP-1 medications—a breakthrough that could transform obesity care. Host Maryam Tabatabai and Carole Kerzic talk about these once-daily pills, and their potential for the similar benefits as injectables without needles or refrigeration. With potential approval coming soon, oral GLP-1s could expand access, impact adherence, and help reshape the weight-loss market. Staying informed is critical: these drugs not only aid weight management but also improve cardiometabolic health. Tune in to learn why understanding the latest developments matters for payers, clinicians, patients, and policymakers. GLP-1 Pipeline Update: November 2025 00:00 Overview 00:49 Introduction to oral GLP-1s 02:43 Evidence from clinical trials 10:28 Big picture if FDA approves oral GLP-1s 14:08 Must know: Non-peptide vs peptide 15:45 More patient friendly formulation? 17:38 Market & timing for oral GLP-s  Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

    Beyond the Needle: Why Oral GLP-1s Matter Now
See All (55)

Trailer

5
out of 5
12 Ratings

About

Pharmacy Friends is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future, and most importantly, what it means to you.

Information

  • Creator
    Prime Therapeutics
  • Years Active
    2021 - 2026
  • Episodes
    55
  • Rating
    Clean
  • Copyright
    © Prime Therapeutics
  • Show Website
    Pharmacy Friends